Lucus Advisors LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 4,921 shares of the pharmacy operator’s stock, valued at approximately $409,000.

Other large investors have also bought and sold shares of the company. Wellington Management Group LLP boosted its stake in Walgreens Boots Alliance by 5.9% in the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after buying an additional 1,824,300 shares during the last quarter. Nordea Investment Management AB boosted its stake in Walgreens Boots Alliance by 26.5% in the first quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock valued at $760,267,000 after buying an additional 1,917,082 shares during the last quarter. TIAA CREF Investment Management LLC boosted its stake in Walgreens Boots Alliance by 22.4% in the first quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock valued at $437,632,000 after buying an additional 962,959 shares during the last quarter. UBS Asset Management Americas Inc. boosted its stake in Walgreens Boots Alliance by 22.9% in the first quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock valued at $407,982,000 after buying an additional 914,888 shares during the last quarter. Finally, Legal & General Group Plc boosted its stake in Walgreens Boots Alliance by 4.6% in the first quarter. Legal & General Group Plc now owns 4,327,670 shares of the pharmacy operator’s stock valued at $359,422,000 after buying an additional 191,698 shares during the last quarter. Hedge funds and other institutional investors own 61.17% of the company’s stock.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded down 0.73% during mid-day trading on Thursday, hitting $80.69. 548,783 shares of the stock traded hands. The stock’s 50 day moving average is $78.91 and its 200-day moving average is $82.32. The company has a market cap of $86.35 billion, a price-to-earnings ratio of 20.38 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a 12 month low of $75.18 and a 12 month high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same quarter last year, the business earned $1.18 earnings per share. Walgreens Boots Alliance’s revenue was up 2.1% compared to the same quarter last year. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post $5.01 EPS for the current year.

Walgreens Boots Alliance announced that its Board of Directors has initiated a share buyback program on Thursday, June 29th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 1.97%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 37.78%.

ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/10/lucus-advisors-llc-buys-shares-of-4921-walgreens-boots-alliance-inc-nasdaqwba.html.

WBA has been the topic of several research analyst reports. Morgan Stanley reiterated an “overweight” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Citigroup Inc. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Thursday, August 3rd. Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Finally, Jefferies Group LLC lowered their price objective on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, May 31st. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and a consensus price target of $90.69.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 13.50% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.